Maximus Tribe

Public Maximus materials describe tiered men’s hormone programs that feature enclomiphene as a core oral option, with higher tiers adding coaching and additional optimization tools. Exact medications and doses are individualized after labs; the King naming refers to bundled services, not a single FDA product SKU.

Third-party roundups often cite roughly $120-$199 per month depending on annual versus month-to-month billing, plus per-draw lab fees (commonly cited around $70+ per required lab in some guides). This comparison page uses a rounded ~$99 starting anchor from older public summaries-confirm live pricing on maximustribe.com because tiers change.

All three operate U.S. telehealth, but Maximus emphasizes protocol structure and optional combination approaches; Hims is higher-volume async DTC; Hone emphasizes membership plus broad diagnostics. Monthly numbers alone don’t capture it: on this grid Maximus and Hims both sit near $99 while Hone lists about $149-yet lab frequency and bundled coaching can invert value once you add required testing.

Enclomiphene is generally aimed at secondary hypogonadism (inadequate pituitary drive with low-normal LH/FSH patterns). Primary hypogonadism (elevated LH/FSH with low testosterone) typically responds poorly to SERMs; exogenous testosterone or other pathways may be considered. Only a clinician interpreting your labs can classify your case.

Higher Maximus tiers advertise human coaching and education layers beyond shipping capsules. Whether coaching is included depends on the tier you purchase; review the checkout page for your selected program.